An integrated pan-cancer analysis of leucine-rich repeat containing protein 59: a potential biomarker for prognostic and immunotherapy
- 21 November 2023
- journal article
- research article
- Published by Springer Nature in Genome Instability & Disease
- Vol. 4 (6) , 333-348
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- Molecular pathogenesis of triple-negative breast cancer based on microRNA expression signatures: antitumor miR-204-5p targets AP1S3Journal of Human Genetics, 2018
- Subcellular localisation of the stem cell markers OCT4, SOX2, NANOG, KLF4 and c-MYC in cancer: a reviewJournal of Clinical Pathology, 2017
- Toil enables reproducible, open source, big biomedical data analysesNature Biotechnology, 2017
- Translating Proteomic Into Functional Data: An High Mobility Group A1 (HMGA1) Proteomic Signature Has Prognostic Value in Breast CancerMolecular & Cellular Proteomics, 2016
- LRRC59 Regulates Trafficking of Nucleic Acid–Sensing TLRs from the Endoplasmic Reticulum via Association with UNC93B1The Journal of Immunology, 2015
- Leucine-rich repeat-containing protein 59 mediates nuclear import of cancerous inhibitor of PP2A in prostate cancer cellsTumor Biology, 2015
- Novel Fusion Transcripts Associate with Progressive Prostate CancerThe American Journal of Pathology, 2014
- Nuclear Import of Exogenous FGF1 Requires the ER‐Protein LRRC59 and the Importins Kpnα1 and Kpnβ1Traffic, 2012
- Human leucine-rich repeat proteins: a genome-wide bioinformatic categorization and functional analysis in innate immunityProceedings of the National Academy of Sciences, 2010
- The landscape of somatic copy-number alteration across human cancersNature, 2010